BACKGROUND Passive immunotherapy with convalescent plasma (CP) is a potential
treatment for COVID-19. Evidence from controlled clinical trials is inconclusive. METHODS We …

Evidence to support the use of steroids in coronavirus disease 2019 (COVID-19) pneumonia
is lacking. We aim to determine the impact of steroid use for COVID-19 pneumonia on …

… biochemical tests (including lactate dehydrogenase), C reactive protein, D Dimer, interleukin-6
(… inflammatory marker abnormalities such as higher D-dimer and C-reactive protein levels. …

… Blood samples will be obtained for routine blood tests, serology tests (HIV-, syphilis, HBV,
and HCV), and bone turnover marker tests (bone-specific alkaline phosphatase (BAP), C-…

Intravenous immunoglobulin (IVIG) use in non-approved indications, the increase in consumption
and its high cost recommend rationalisation in its utilisation. Aims To assess the use of …

… Levels of analytical markers (C-Reactive Protein, lymphocyte and neutrophil counts,
lymphocyte subpopulations, LDH, ferritin, D-dimer, coagulation tests and cytokines...) at baseline …

Introducción El objetivo de este estudio fue evaluar el grado de conocimiento y las necesidades
de formación sobre fármacos biosimilares en los médicos de Atención Primaria (AP). …

The humoral immune response against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
variants of concern elicited by vaccination was evaluated in COVID‐19 …

Mesenchymal stromal cells (MSC) have immunomodulatory and tissue-regenerative
properties and have shown promising results in acute respiratory distress syndrome (ARDS) of …

Highlights • Avapritinib is a protein kinase inhibitor designed to inhibit oncogenic KIT and
PDGFRA mutants. • A marketing authorisation was issued for avapritinib as treatment of …